TMS: Deeper is not Better
The Carlat Psychiatry Report, Volume 18, Number 1, January 2020
https://www.thecarlatreport.com/newsletter-issue/tcprv18n1/
Issue Links: Learning Objectives | Editorial Information
Topics: Depression | Depressive Disorder | Pharmaceutical Industry | Research Update | rTMS | TMS | Transcranial Magnetic Stimulation | Treatment-Resistant Depression
Edmund S. Higgins, MD.
Dr. Higgins has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Two devices are available for transcranial magnetic stimulation (TMS). Neurostar came first with the figure-8 coil, which is now off-patent, while Brainsway’s H-coil which claims to reach deeper into the cerebral cortex. See how they compare in the first head-to-head controlled trial, undertaken without industry support.
You can't view details of this content, please login or buy subscription here